A Newly Uncovered Mechanism Underlying Resistance to Immune Checkpoint Inhibition
Immune checkpoint inhibition is a form of cancer immunotherapy that works by releasing the “brakes” on the immune system, thereby increasing...
Immune checkpoint inhibition is a form of cancer immunotherapy that works by releasing the “brakes” on the immune system, thereby increasing...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...
Genomic analysis of estrogen receptor (ER)-positive metastatic breast cancer samples that had become resistant to therapies revealed multiple alterations...
This post explores the challenges we face with anti-EGFR monoclonal antibody therapies and new strategies researchers have developed to...
Currently, anti-EGFR therapies are approved by the U.S. Food and Drug Administration for the treatment of non-small cell lung...